Akoya Biosciences, Inc. Quarterly Operating Income (Loss) in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Akoya Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q3 2024.
  • Akoya Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$8.35M, a 27.7% increase year-over-year.
  • Akoya Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$50.5M, a 23.3% increase year-over-year.
  • Akoya Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$57.7M, a 12.8% increase from 2022.
  • Akoya Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$66.1M, a 68.2% decline from 2021.
  • Akoya Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$39.3M, a 227% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$50.5M -$8.35M +$3.2M +27.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$53.7M -$11.1M +$8.16M +42.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$61.8M -$21.6M -$4.15M -23.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$57.7M -$9.44M +$8.15M +46.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 -$65.8M -$11.6M +$5.1M +30.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$70.9M -$19.2M -$2.93M -18% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$68M -$17.4M -$1.88M -12.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$66.1M -$17.6M -$811K -4.83% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$65.3M -$16.7M -$5.91M -55.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$59.4M -$16.3M -$9.93M -156% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$49.5M -$15.6M -$10.2M -188% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$39.3M -$16.8M -$13.6M -433% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 -$25.7M -$10.7M -$7.07M -193% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$18.6M -$6.38M -$2.55M -66.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$16M -$5.4M -$4.04M -296% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$12M -$3.15M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 -$3.67M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$3.83M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$1.36M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.